U.S., Oct. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07871760) titled 'Long-Term Quality Of Life And Symptom Assessment Among Recurrence-Free Patients Who Underwent Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy' on Oct. 08.
Brief Summary: To evaluate long-term quality of life (QoL) and participant reported symptom burden in disease-free survivors who have undergone cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) at MD Anderson, with primary emphasis on overall (composite) QoL as measured by validated instruments.
Study Start Date: March 22, 2027
Study Type: OBSERVATIONAL
Condition:
Long Term
Quality of Life
Recurrence Free
Cytoreductive Surgery...